Literature DB >> 28607023

Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.

Osvaldo Álvarez1, Jose Cristian Plaza-Plaza2, Manuel Ramirez1, Alexis Peralta3, Cristián A Amador4, Roberto Amador5.   

Abstract

The vancomycin loading dose (LD) of 25 to 30 mg/kg is a frequently practiced strategy to achieve effective concentrations from the first-treatment dose. However, considering only the body weight for dosing might be inadequate in critically ill patients due to pharmacokinetics changes. We sought to assess achieving optimal trough serum levels of vancomycin and AUC0-24/MIC in the first 24 h of treatment by using an LD based on population pharmacokinetic parameters of critically ill patients. We performed a concurrent cohort study over 22 months of patients with severe sepsis who received intravenous vancomycin. The patients were treated with three different strategies to initiate vancomycin: without an LD (group A), with an LD of 25 to 30 mg/kg (group B), and with an LD based on population pharmacokinetic parameters of the critically ill patient (group C). An optimal trough serum concentration was achieved in 5, 9, and 83% of patients in groups A, B, and C, respectively. The number of patients that reached optimal AUC0-24 was 2 of 18 (11%), 5 of 11 (46%), and 11 of 12 (92%) in groups A, B, and C, respectively. The statistical analysis for both parameters revealed significant differences in group C with respect to other groups. The administration of the LD calculated from population pharmacokinetic parameters from the beginning of therapy is a more efficient strategy to obtain adequate trough serum concentrations and AUC0-24/MIC in critical patients.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  critical care; pharmacokinetics; vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28607023      PMCID: PMC5527600          DOI: 10.1128/AAC.00280-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

Authors:  S J van Hal; T P Lodise; D L Paterson
Journal:  Clin Infect Dis       Date:  2012-02-02       Impact factor: 9.079

Review 2.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

3.  Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Authors:  Kazuaki Matsumoto; Yoshio Takesue; Norio Ohmagari; Takahiro Mochizuki; Hiroshige Mikamo; Masafumi Seki; Shunji Takakura; Issei Tokimatsu; Yoshiko Takahashi; Kei Kasahara; Kenji Okada; Masahiro Igarashi; Masahiro Kobayashi; Yukihiro Hamada; Masao Kimura; Yoshifumi Nishi; Yusuke Tanigawara; Toshimi Kimura
Journal:  J Infect Chemother       Date:  2013-05-15       Impact factor: 2.211

4.  Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.

Authors:  Tina Harrach Denetclaw; Thomas C Dowling; Douglas Steinke
Journal:  Ann Pharmacother       Date:  2013-10-25       Impact factor: 3.154

5.  High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients.

Authors:  Jamie M Rosini; Joshua J Davis; Jeffrey Muenzer; Brian J Levine; Mia A Papas; Dominique Comer; Ryan Arnold
Journal:  Acad Emerg Med       Date:  2016-05-14       Impact factor: 3.451

6.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia.

Authors:  Natasha E Holmes; John D Turnidge; Wendy J Munckhof; J Owen Robinson; Tony M Korman; Matthew V N O'Sullivan; Tara L Anderson; Sally A Roberts; Sanchia J C Warren; Wei Gao; Benjamin P Howden; Paul D R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-01-18       Impact factor: 5.191

8.  Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg.

Authors:  I Mohammedi; E Descloux; L Argaud; J Le Scanff; D Robert
Journal:  Int J Antimicrob Agents       Date:  2006-02-10       Impact factor: 5.283

9.  The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*.

Authors:  Andrew Labelle; Paul Juang; Richard Reichley; Scott Micek; Justin Hoffmann; Alex Hoban; Nicholas Hampton; Marin Kollef
Journal:  Crit Care Med       Date:  2012-07       Impact factor: 7.598

Review 10.  Vancomycin therapeutics and monitoring: a contemporary approach.

Authors:  M L Avent; V L Vaska; B A Rogers; A C Cheng; S J van Hal; N E Holmes; B P Howden; D L Paterson
Journal:  Intern Med J       Date:  2013-02       Impact factor: 2.048

View more
  8 in total

Review 1.  Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design.

Authors:  Umar Ndagi; Abubakar A Falaki; Maryam Abdullahi; Monsurat M Lawal; Mahmoud E Soliman
Journal:  RSC Adv       Date:  2020-05-14       Impact factor: 4.036

2.  Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's Complicated.

Authors:  Jessica K Ortwine; Evan J Zasowski; Jason M Pogue; Claudia Hanni; Chris Giuliano; Anthony M Casapao; Ryan Mynatt; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2019-10-21

3.  Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Jin Gu Yoon; Kyungmin Huh; You Min Sohn; Hyo Jung Park; Soo Jin Na; Kyeongman Jeon
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

4.  Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).

Authors:  Marcus Kirwan; Reema Munshi; Hannah O'Keeffe; Conor Judge; Mary Coyle; Evelyn Deasy; Yvelynne P Kelly; Peter J Lavin; Maria Donnelly; Deirdre M D'Arcy
Journal:  Crit Care       Date:  2021-12-20       Impact factor: 9.097

5.  The clinical efficacy and safety of vancomycin loading dose: A systematic review and meta-analysis.

Authors:  Hekun Mei; Jin Wang; Haoyue Che; Rui Wang; Yun Cai
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

Review 6.  A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients.

Authors:  Abdul Haseeb; Mayyasah Khalid Alqurashi; Areej Sultan Althaqafi; Jumana Majdi Alsharif; Hani Saleh Faidah; Mashael Bushyah; Amal F Alotaibi; Mahmoud Essam Elrggal; Ahmad Jamal Mahrous; Safa S Almarzoky Abuhussain; Najla A Obaid; Manal Algethamy; Abdullmoin AlQarni; Asim A Khogeer; Zikria Saleem; Muhammad Shahid Iqbal; Sami S Ashgar; Aziz Sheikh
Journal:  Antibiotics (Basel)       Date:  2022-03-18

Review 7.  Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Authors:  Kazuaki Matsumoto; Kazutaka Oda; Kensuke Shoji; Yuki Hanai; Yoshiko Takahashi; Satoshi Fujii; Yukihiro Hamada; Toshimi Kimura; Toshihiko Mayumi; Takashi Ueda; Kazuhiko Nakajima; Yoshio Takesue
Journal:  Pharmaceutics       Date:  2022-02-23       Impact factor: 6.321

8.  Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.

Authors:  C J Hodiamont; N P Juffermans; S E Berends; D J van Vessem; N Hakkens; R A A Mathôt; M D de Jong; R M van Hest
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.